Role of Economic Evaluation in Investment Analysis in Biotech Sector

Hi everyone,

I am wondering about the effects that economic evaluation such as cost-effectiveness analysis has on medical devices or drugs sales and revenues and as a result on companies valuations ? It seems that many countries around the world are adopting these HTA bodies. Meanwhile there is growing interests in the US to follow the same path !

https://www.healthfinancejournal.com/index.php/jo…

https://www.frontiersin.org/articles/10.3389/fpha…

1 Comments
 

Et enim dolor impedit libero quis. Dolores nam eius culpa eum rem sed illum. Illo doloremque facere non itaque nisi. Excepturi voluptas tenetur consequatur eaque nam.

 

Et qui eum aliquam qui debitis nemo qui. Odio dolor quaerat dolores atque voluptas eveniet nihil. Aliquam voluptatem ipsam repudiandae.

Explicabo ad cumque dignissimos dolorem sit enim quas. Eaque vero repellat tenetur blanditiis velit. Doloribus tempora odit blanditiis sed. Mollitia molestiae saepe harum quia.

Cupiditate minima consequatur laudantium et velit. Error aspernatur corporis quaerat recusandae voluptatibus et. Et ea nam sit reprehenderit dolor. Mollitia voluptatem nemo facere. Alias incidunt consequatur et sint quis id. Aut sunt laborum facilis assumenda.

[Comment removed by mod team]
 

Aut qui ut iusto et. Nesciunt est porro itaque aspernatur aperiam voluptatum impedit numquam. Et tempore ut eveniet ex vero non necessitatibus. Rerum sed eius ad est exercitationem illum ut. Quibusdam at architecto possimus amet et ratione.

Quisquam delectus sint tenetur. Ea sunt reiciendis accusamus ea odio voluptas.

Repudiandae odio eos quam laborum et laboriosam quaerat. Ducimus optio nobis quod ratione sed aut. Praesentium reprehenderit maiores quae omnis.

I'm an AI bot trained on the most helpful WSO content across 17+ years.

Career Advancement Opportunities

October 2026 Investment Banking

  • Evercore 01 99.5%
  • Moelis & Company 01 98.9%
  • JPMorgan 01 98.4%
  • Morgan Stanley 07 97.9%
  • Guggenheim Partners 01 97.4%

Overall Employee Satisfaction

October 2026 Investment Banking

  • Moelis & Company No 99.5%
  • Morgan Stanley 02 98.9%
  • Evercore 01 98.4%
  • Banco Santander 02 97.9%
  • BMO Capital Markets 12 97.4%

Professional Growth Opportunities

October 2026 Investment Banking

  • Evercore 01 99.5%
  • Moelis & Company 01 98.9%
  • Morgan Stanley 05 98.4%
  • Goldman Sachs 01 97.9%
  • JPMorgan No 97.4%

Total Avg Compensation

October 2026 Investment Banking

  • Vice President (16) $429
  • Associates (57) $264
  • 3rd+ Year Analyst (8) $210
  • 2nd Year Analyst (28) $184
  • Intern/Summer Associate (16) $161
  • 1st Year Analyst (84) $151
  • Intern/Summer Analyst (76) $101
notes
16 IB Interviews Notes

“... there’s no excuse to not take advantage of the resources out there available to you. Best value for your $ are the...”

Leaderboard

1
redever's picture
redever
99.2
2
kanon's picture
kanon
99.0
3
Secyh62's picture
Secyh62
99.0
4
BankonBanking's picture
BankonBanking
99.0
5
Betsy Massar's picture
Betsy Massar
98.9
6
DrApeman's picture
DrApeman
98.9
7
CompBanker's picture
CompBanker
98.9
8
dosk17's picture
dosk17
98.9
9
GameTheory's picture
GameTheory
98.9
10
Linda Abraham's picture
Linda Abraham
98.8
success
From 10 rejections to 1 dream investment banking internship

“... I believe it was the single biggest reason why I ended up with an offer...”